Published Date:2024-11-11 Original Link:https://www.onenessbio.com/en/news_detail327_1.htm No 3 Date of announcement 2024/11/11 Time of announcement 17:27:21 Subject Announcement of the Company’s board of directors’ resolution on the change of the cash capital increase plan for 2020 To which item it meets paragraph 16 Date of events 2024/11/11 Statement Date of the board of directors resolution for the...Read More

Published Date:2024-11-04 Original Link:https://www.onenessbio.com/en/news_detail325_1.htm No 1 Date of announcement 2024/11/04 Time of announcement 20:51:08 Subject Bonvadis topical cream received medical device marketing authorization approval for all indications in wounds for Saudi Arabia To which item it meets paragraph 10 Date of events 2024/11/04 Statement Date of occurrence of the event: 2024/11/04 New drug name or...Read More

Published Date:2024-10-30 Original Link:https://www.onenessbio.com/en/news_detail324_1.htm No 1 Date of announcement 2024/10/30 Time of announcement 17:46:52 Subject Announcement of the date of the Company’s board of directors meeting for the Thired Quarter of 2024 Consolidated Financial Reports To which item it meets paragraph 31 Date of events 2024/10/30 Statement Date of a notice of the board of...Read More

Published Date:2024-09-27 Original Link:https://www.onenessbio.com/en/news_detail323_1.htm No 2 Date of announcement 2024/09/27 Time of announcement 17:34:49 Subject A US patent titled “Biomarkers for lung cancer stem cells” has been granted To which item it meets paragraph 53 Date of events 2024/09/27 Statement Date of occurrence of the event: 2024/09/27 Company name: ONENESS BIOTECH CO., LTD. Relationship to...Read More

Published Date:2024-09-27 Original Link:https://www.onenessbio.com/en/news_detail322_1.htm No 1 Date of announcement 2024/09/27 Time of announcement 17:33:59 Subject Oneness Biotech Co., Ltd. receives a United States patent titled “TREATING IGE-MEDIATED ALLERGIC DISEASES” on FB825. To which item it meets paragraph 53 Date of events 2024/09/27 Statement Date of occurrence of the event: 2024/09/27 Company name: ONENESS BIOTECH CO.,...Read More

Published Date:2024-09-20 Original Link:https://www.onenessbio.com/en/news_detail321_1.htm No 1 Date of announcement 2024/09/20 Time of announcement 18:46:22 Subject Oneness has received medical device registration approval on Bonvadis Topical Cream for Egypt To which item it meets paragraph 10 Date of events 2024/09/20 Statement Date of occurrence of the event: 2024/09/20 New drug name or code: Bonvadis Indication: Bonvadis...Read More

Published Date:2024-09-18 Original Link:https://www.onenessbio.com/en/news_detail320_1.htm No 1 Date of announcement 2024/09/18 Time of announcement 17:43:20 Subject Oneness announces the information about the investor’s conference of 2024 Q3. To which item it meets paragraph 12 Date of events 2024/09/25 Statement Date of institutional investor conference: 2024/09/25 Time of institutional investor conference: 15:00 (GMT+8) Location of institutional investor...Read More

Published Date:2024-09-15 Original Link:https://www.onenessbio.com/en/news_detail319_1.htm No 1 Date of announcement 2024/09/15 Time of announcement 20:15:58 Subject National Health Security Administration of China has not included Fespixon Cream in this year NRDL adjustment negotiation after the expert review. To which item it meets paragraph 53 Date of events 2024/09/14 Statement Date of occurrence of the event: 2024/09/14...Read More

Published Date:2024-09-08 Original Link:https://www.onenessbio.com/en/news_detail317_1.htm No 1 Date of announcement 2024/09/08 Time of announcement 17:16:12 Subject SNS812 Phase 2 study demonstrated statistical significance in treating COVID-19 based on its safety, precision and broad-spectrum efficacy. To which item it meets paragraph 10 Date of events 2024/09/06 Statement Date of occurrence of the event: 2024/09/06 New drug name...Read More

Published Date:2024-09-08 Original Link:https://www.onenessbio.com/en/news_detail318_1.htm No 2 Date of announcement 2024/09/08 Time of announcement 18:18:59 Subject Oneness & Microbio (Shanghai) host an international press conference to present the pan-COVID new drug, SNS812 Phase 2 clinical trial results and future prospects To which item it meets paragraph 53 Date of events 2024/09/08 Statement Date of occurrence of...Read More